等待开盘 07-29 09:30:00 美东时间
0.000
0.00%
Jupiter Neurosciences (NASDAQ: JUNS) has regained compliance with Nasdaq's continued listing standard for minimum share price under Rule 5550(a)(2). The Company's common stock maintained an average closing price of at least $1.00 over 13 consecutive days (June 18-July 8, 2025), resolving its non-compliance issue. This milestone was disclosed in a Form 8-K filed on July 10, 2025.
07-10 20:05
今冬初雪已至,寒意加剧。Biotech早已开始了寒冬蛰伏,big pharma则在伺机“捡漏”。因为后者通常手握巨额现金,且都有着强烈的管线补充意愿。 今年以来...
2023-12-11 20:18
Equities research analysts at StockNews.com initiated coverage on shares of Jou...
2023-04-14 13:24
Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) Director Richard /Ca/ Murr...
2023-04-08 18:03
Analysts at StockNews.com assumed coverage on shares of Jounce Therapeutics (NA...
2023-04-06 13:51
StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – ...
2023-04-02 16:31
北京时间2023年03月15日21时33分,Morphosys(MOR.us)股票出现异动,股价大幅下跌5.79%。截至发稿,该股报3.74美元/股,成交量4...
2023-03-15 23:06
北京时间2023年03月15日21时57分,Rezolute Inc(RZLT.us)股票出现波动,股价急速拉升5.36%。截至发稿,该股报2.39美元/股,成...
2023-03-15 22:48
美股银行股盘前再度走高,阿莱恩斯西部银行涨超11%,西太平洋银行涨超7%;嘉信理财盘前涨超4%,公司CEO买入自家股票以提振信心>>
2023-03-15 16:23
Shares of Jounce Therapeutics, Inc. (NASDAQ:JNCE – Get Rating) have earned an a...
2023-03-03 15:43